Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2013

01-01-2013 | Original Article

High Expression of Calcitonin Gene-Related Peptide and Substance P in Esophageal Mucosa of Patients with Non-Erosive Reflux Disease

Authors: Xiaorong Xu, Zhaoshen Li, Duowu Zou, Min Yang, Zhanju Liu, Xingpeng Wang

Published in: Digestive Diseases and Sciences | Issue 1/2013

Login to get access

Abstract

Background

Visceral hypersensitivity is an important etiology of non-erosive reflux disease (NERD). Calcitonin gene-related peptide (CGRP) and substance P (SP) are involved in the sensitization of afferent neuronal pathways.

Aim

The objectives of this study were to evaluate visceral hypersensitivity in NERD patients, investigate the association between visceral hypersensitivity and mucosal expression of SP and CGRP, and assess their involvement in the pathogenesis of NERD.

Methods

Twenty-six NERD patients and 12 healthy volunteers were recruited. Intraesophageal balloon distention was performed, and initial perception threshold (IPT) and threshold of discomfort (ToD) were determined. Immunohistochemical staining was used to measure the optical density (OD) of CGRP and SP-reactive levels in esophageal mucosa, and the numbers of CGRP and SP-reactive neural fibers.

Results

IPT and ToD were 9.6 ± 4.8 and 12.3 ± 3.2 ml, respectively, in NERD patients, significantly lower than for controls (13.2 ± 7.5 and 21.6 ± 5.7 ml, P < 0.05 and P < 0.01, respectively). Mean OD values for CGRP and SP staining were significantly higher in NERD than for controls (both P < 0.05) and, in NERD, were negatively correlated with IPT and ToD (all P < 0.01). Numbers of CGRP and SP-reactive neural fibers in esophageal submucosa of NERD patients were significantly increased (both P < 0.05).

Conclusions

Expression of esophageal epithelial CGRP and SP is increased, and correlates negatively with perception thresholds in NERD. These findings may aid understanding of peripheral visceral hypersensitivity and the development of new therapeutic approaches for management of NERD.
Literature
1.
go back to reference Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:s2–s7.PubMedCrossRef Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:s2–s7.PubMedCrossRef
2.
go back to reference Chey WD. Endoscopy-negative reflux disease: concepts and clinical practice. Am J Med. 2004;117:36S–43S.PubMed Chey WD. Endoscopy-negative reflux disease: concepts and clinical practice. Am J Med. 2004;117:36S–43S.PubMed
3.
go back to reference Hershcovici T, Fass R. Nonerosive reflux disease (NERD)-an update. J Neurogastroenterol Motil. 2010;16:8–21.PubMedCrossRef Hershcovici T, Fass R. Nonerosive reflux disease (NERD)-an update. J Neurogastroenterol Motil. 2010;16:8–21.PubMedCrossRef
4.
go back to reference Sarnelli G, Vandenberghe J, Tack J. Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract. Dig Liver Dis.. 2004;36:371–376.PubMed Sarnelli G, Vandenberghe J, Tack J. Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract. Dig Liver Dis.. 2004;36:371–376.PubMed
5.
go back to reference Miwa H, Kondo T, Oshima T, Fukui H, Tomita T, Watari J. Esophageal sensation and esophageal hypersensitivity-overview from bench to bedside. J Neurogastroenterol Motil. 2010;16:353–362.PubMedCrossRef Miwa H, Kondo T, Oshima T, Fukui H, Tomita T, Watari J. Esophageal sensation and esophageal hypersensitivity-overview from bench to bedside. J Neurogastroenterol Motil. 2010;16:353–362.PubMedCrossRef
6.
go back to reference Sarkar S, Thompson DG, Woolf CJ, Hobson AR, Millane T, Aziz Q. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol. 2004;99:1998–2006.PubMedCrossRef Sarkar S, Thompson DG, Woolf CJ, Hobson AR, Millane T, Aziz Q. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol. 2004;99:1998–2006.PubMedCrossRef
7.
go back to reference Miwa H, Minoo T, Hojo M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112–117.PubMedCrossRef Miwa H, Minoo T, Hojo M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112–117.PubMedCrossRef
8.
go back to reference Azpiroz F. Gastrointestinal perception: pathophysiological implications. J Neurogastroenterol Motil. 2002;14:229–239.CrossRef Azpiroz F. Gastrointestinal perception: pathophysiological implications. J Neurogastroenterol Motil. 2002;14:229–239.CrossRef
9.
go back to reference Bueno L, Fioramonti J. Visceral perception: inflammatory and non-inflammatory mediators. Gut. 2002;51:i19–i23.PubMedCrossRef Bueno L, Fioramonti J. Visceral perception: inflammatory and non-inflammatory mediators. Gut. 2002;51:i19–i23.PubMedCrossRef
10.
go back to reference Lian B, Vera-Portocarrero L. Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity (CGRP). Brain Res. 2010;28:64–70.CrossRef Lian B, Vera-Portocarrero L. Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity (CGRP). Brain Res. 2010;28:64–70.CrossRef
11.
go back to reference Delafoy L, Gelot A, Ardid D, et al. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut. 2006;55:940–945.PubMedCrossRef Delafoy L, Gelot A, Ardid D, et al. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut. 2006;55:940–945.PubMedCrossRef
12.
go back to reference Lin C, Al-Chaer ED. Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res. 2003;971:73–82.PubMedCrossRef Lin C, Al-Chaer ED. Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res. 2003;971:73–82.PubMedCrossRef
13.
go back to reference Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1196–G1202.PubMed Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1196–G1202.PubMed
14.
go back to reference Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol. 1997;273:191–196. Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol. 1997;273:191–196.
15.
go back to reference Gschossmann JM, Coutinho SV, Miller JC, et al. Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat. Neurogastroenterol Motil. 2001;13:229–236.PubMedCrossRef Gschossmann JM, Coutinho SV, Miller JC, et al. Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat. Neurogastroenterol Motil. 2001;13:229–236.PubMedCrossRef
16.
go back to reference Maggi CA. Tachykinin as peripheral modulators of primary afferent nerves and visceral sensitivity. Pharmacol Res. 1997;36:153–169.PubMedCrossRef Maggi CA. Tachykinin as peripheral modulators of primary afferent nerves and visceral sensitivity. Pharmacol Res. 1997;36:153–169.PubMedCrossRef
17.
go back to reference Mönnikes H, van der Voort IR, Wollenberg B, et al. Gastric perception thresholds are low and sensory neuropeptide levels high in Helicobacter pylori-positive functional dyspepsia. Digestion. 2005;71:111–123.PubMedCrossRef Mönnikes H, van der Voort IR, Wollenberg B, et al. Gastric perception thresholds are low and sensory neuropeptide levels high in Helicobacter pylori-positive functional dyspepsia. Digestion. 2005;71:111–123.PubMedCrossRef
18.
go back to reference Giorgio RD, Barbara G, Blennerhassett P, et al. Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat. Gut 2001;49:822–827. Giorgio RD, Barbara G, Blennerhassett P, et al. Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat. Gut 2001;49:822–827.
20.
go back to reference Rao SS, Hayek B, Mudipalli R, Gregersen H. Does esophageal function vary at the striated and smooth muscle segments in functional chest pain? Am J Gastroenterol. 2002;97:2201–2207.PubMedCrossRef Rao SS, Hayek B, Mudipalli R, Gregersen H. Does esophageal function vary at the striated and smooth muscle segments in functional chest pain? Am J Gastroenterol. 2002;97:2201–2207.PubMedCrossRef
21.
go back to reference Galmiche JP, Scarpignato C. Oesophageal sensitivity to acid in patients with non-cardiac chest pain: is the oesophagus hypersensitive? Eur J Gastroenterol Hepatol. 1995;7:1152–1159.PubMedCrossRef Galmiche JP, Scarpignato C. Oesophageal sensitivity to acid in patients with non-cardiac chest pain: is the oesophagus hypersensitive? Eur J Gastroenterol Hepatol. 1995;7:1152–1159.PubMedCrossRef
22.
go back to reference Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut. 2008;57:674–683.PubMedCrossRef Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut. 2008;57:674–683.PubMedCrossRef
23.
go back to reference Chahal PS, Rao SS. Functional chest pain: nociception and visceral hyperalgesia. J Clin Gastroenterol. 2005;39:S204–S209.PubMedCrossRef Chahal PS, Rao SS. Functional chest pain: nociception and visceral hyperalgesia. J Clin Gastroenterol. 2005;39:S204–S209.PubMedCrossRef
24.
go back to reference Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut. 2002;51:i2–i5.PubMedCrossRef Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut. 2002;51:i2–i5.PubMedCrossRef
25.
go back to reference Szurszexski JH, Ermilov LG, Miller SM. Prevertebral ganglia and intestinofugal afferent neurons. Gut 2002;51:i6–i10. Szurszexski JH, Ermilov LG, Miller SM. Prevertebral ganglia and intestinofugal afferent neurons. Gut 2002;51:i6–i10.
26.
go back to reference Myers AC, Kajekar R, Undem BJ. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol. 2002;282:L775–L781.PubMed Myers AC, Kajekar R, Undem BJ. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol. 2002;282:L775–L781.PubMed
27.
go back to reference Sun RQ, Lawand NB, Willis WD. The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain. 2003;104:201–208.PubMedCrossRef Sun RQ, Lawand NB, Willis WD. The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain. 2003;104:201–208.PubMedCrossRef
28.
go back to reference Rodrigo J, Polak JM, Fernandez L, Ghatei MA, Mulderry P, Bloom SR. Calcitonin gene-related peptide immunoreactive sensory and motor nerves of the rat, cat, and monkey esophagus. Gastroenterology. 1985;88:444–451.PubMed Rodrigo J, Polak JM, Fernandez L, Ghatei MA, Mulderry P, Bloom SR. Calcitonin gene-related peptide immunoreactive sensory and motor nerves of the rat, cat, and monkey esophagus. Gastroenterology. 1985;88:444–451.PubMed
29.
go back to reference Chan CLH, Facer P, Davis JB, et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet. 2003;361:385–391.PubMedCrossRef Chan CLH, Facer P, Davis JB, et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet. 2003;361:385–391.PubMedCrossRef
30.
go back to reference Kiesslich R, Kanzler S, Vieth M, et al. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis. 2004;22:221–227.PubMedCrossRef Kiesslich R, Kanzler S, Vieth M, et al. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis. 2004;22:221–227.PubMedCrossRef
31.
go back to reference Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef
Metadata
Title
High Expression of Calcitonin Gene-Related Peptide and Substance P in Esophageal Mucosa of Patients with Non-Erosive Reflux Disease
Authors
Xiaorong Xu
Zhaoshen Li
Duowu Zou
Min Yang
Zhanju Liu
Xingpeng Wang
Publication date
01-01-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2308-z

Other articles of this Issue 1/2013

Digestive Diseases and Sciences 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.